Tag: Emblem Cannabis Corporation

Emblem Corp. Announces New Board Appointments

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board...

Emblem Partners With DriveABLE To Support Research That Evaluates Impairment Risk

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”) today announced it has completed an equity investment in DriveABLE Assessment Centres Inc. (“DriveABLE”),...

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company"), today announced the achievement of a milestone with regards to the development of...

Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...

Emblem launches Atmosphere, its first oral dose-metered spray

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...

Emblem Signs Supply Agreement with Aphria to Purchase up to 175,000 kg Equivalents of Cannabis Products Over Five Years

Emblem (TSXV:EMC,OTCQX:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under...

UPDATE: Emblem Signs Five-Year Supply Agreement with Compass Cannabis Clinic for Starbuds Canada

Emblem (TSXV:EMC, OTC:EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis...